xentuzumab bispecific monoclonal antibody

Explore academic connections and research related to this keyword

189
Views
2
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Model-informed dose selection for Xentuzumab, a dual insulin-like growth factor-I/II -neutralizing antibody.
Parra-Guillen, Zinnia P;Schmid, Ulrike;Janda, Alvaro;Freiwald, Matthias;Troconiz, Iñaki F;
2019 clinical pharmacology and therapeutics DOI: 10.1002/cpt.1648 394 views

Related Journals

clinical pharmacology and therapeutics
ISSN: 1532-6535 1,050 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

systems pharmacology igf-signaling pathway model-informed dose selection target-mediated drug disposition